WallStreetZenWallStreetZen

NASDAQ: PBLS
Parabilis Medicines Revenue

OverviewEarningsRevenue
DividendOwnership
Parabilis Medicines revenue was N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PBLS annual revenue was $0.0, with N/A growth year-over-year.

PBLS revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when PBLS announces revenue.

PBLS Revenue History By Year

PBLS Yearly RevenuePBLS RevenuePBLS ChangePBLS Revenue Growth
2025-12-31$0.00N/AN/A
2024-12-31$0.00N/AN/A

1 of 1

Parabilis Medicines Revenue FAQ

What was PBLS's revenue last quarter?

Parabilis Medicines (NASDAQ: PBLS) reported Q1 2026 revenue of $0.00 up N/A year over year. In the same quarter last year, Parabilis Medicines's revenue was $0.00.

What was Parabilis Medicines's revenue in 2025?

Parabilis Medicines's annual revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.

How much does Parabilis Medicines make in a day?

Based on Parabilis Medicines annual revenue for the past one years, PBLS makes an average of $0.00 per day.

What was Parabilis Medicines's annual revenue growth in the past year?

As of Q2 2026, Parabilis Medicines's revenue has grown null year over year. Parabilis Medicines's revenue in the past year totaled N/A.

How much does Parabilis Medicines make in a year?

Parabilis Medicines's revenue by year for the past one years is:
  • Parabilis Medicines's revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.